2012 Q4 Form 10-Q Financial Statement
#000119312512448716 Filed on November 02, 2012
Income Statement
Concept | 2012 Q4 | 2012 Q3 | 2011 Q4 |
---|---|---|---|
Revenue | $100.7M | $126.3M | $100.7M |
YoY Change | 0.0% | 16.85% | 6.89% |
Cost Of Revenue | $56.20M | $67.82M | $70.33M |
YoY Change | -20.09% | 3.55% | 29.11% |
Gross Profit | $41.35M | $58.48M | $44.50M |
YoY Change | -7.08% | 37.47% | 33.65% |
Gross Profit Margin | 41.07% | 46.3% | 44.2% |
Selling, General & Admin | $38.00M | $22.70M | $25.52M |
YoY Change | 48.93% | -0.86% | 29.93% |
% of Gross Profit | 91.89% | 38.82% | 57.33% |
Research & Development | $15.30M | $13.04M | $8.948M |
YoY Change | 70.99% | 60.99% | 44.67% |
% of Gross Profit | 37.0% | 22.3% | 20.11% |
Depreciation & Amortization | $3.500M | $2.900M | $2.600M |
YoY Change | 34.62% | 20.83% | 36.84% |
% of Gross Profit | 8.46% | 4.96% | 5.84% |
Operating Expenses | $53.40M | $35.74M | $34.46M |
YoY Change | 54.95% | 14.93% | 33.46% |
Operating Profit | -$12.05M | $22.73M | $15.58M |
YoY Change | -177.32% | 98.79% | 108.37% |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $197.0K | -$92.00K |
YoY Change | -100.0% | 97.0% | -130.67% |
Pretax Income | -$8.900M | $22.93M | $15.49M |
YoY Change | -157.46% | 97.68% | 101.14% |
Income Tax | -$3.000M | $7.724M | $1.436M |
% Of Pretax Income | 33.68% | 9.27% | |
Net Earnings | -$5.938M | $15.21M | -$5.938M |
YoY Change | 0.0% | 89.52% | -184.83% |
Net Earnings / Revenue | -5.9% | 12.04% | -5.9% |
Basic Earnings Per Share | $0.55 | $0.52 | |
Diluted Earnings Per Share | -$0.21 | $0.54 | -$0.21 |
COMMON SHARES | |||
Basic Shares Outstanding | 27.76M shares | 27.65M shares | 26.90M shares |
Diluted Shares Outstanding | 28.32M shares | 27.94M shares |
Balance Sheet
Concept | 2012 Q4 | 2012 Q3 | 2011 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $139.2M | $189.7M | $145.3M |
YoY Change | -4.2% | 54.86% | 35.54% |
Cash & Equivalents | $126.8M | $169.7M | $166.3M |
Short-Term Investments | $12.40M | $20.10M | $13.70M |
Other Short-Term Assets | $8.853M | $4.608M | $7.928M |
YoY Change | 11.67% | -80.88% | -39.02% |
Inventory | $36.97M | $32.59M | $31.09M |
Prepaid Expenses | |||
Receivables | $29.41M | $53.38M | $43.34M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $234.9M | $296.9M | $284.2M |
YoY Change | -17.34% | 32.89% | 54.03% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $24.95M | $24.84M | $29.03M |
YoY Change | -14.04% | -11.61% | 29.59% |
Goodwill | $48.95M | $7.910M | |
YoY Change | 518.85% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $8.500M | $18.60M | $2.500M |
YoY Change | 240.0% | -2.62% | -86.56% |
Total Long-Term Assets | $119.4M | $53.86M | $48.03M |
YoY Change | 148.62% | 6.66% | 8.18% |
TOTAL ASSETS | |||
Total Short-Term Assets | $234.9M | $296.9M | $284.2M |
Total Long-Term Assets | $119.4M | $53.86M | $48.03M |
Total Assets | $354.3M | $350.7M | $332.2M |
YoY Change | 6.65% | 28.05% | 45.13% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $42.52M | $38.32M | $48.41M |
YoY Change | -12.17% | 15.07% | 35.59% |
Accrued Expenses | $13.64M | $18.71M | $17.19M |
YoY Change | -20.63% | -30.43% | -34.89% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $74.28M | $68.19M | $85.00M |
YoY Change | -12.61% | 9.45% | 30.97% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $4.200M | $3.900M | $3.700M |
YoY Change | 13.51% | 0.0% | 0.0% |
Total Long-Term Liabilities | $4.218M | $3.940M | $4.255M |
YoY Change | -0.87% | 1.03% | 15.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $74.28M | $68.19M | $85.00M |
Total Long-Term Liabilities | $4.218M | $3.940M | $4.255M |
Total Liabilities | $78.50M | $72.13M | $89.26M |
YoY Change | -12.05% | 9.11% | 30.11% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $75.44M | $81.38M | $58.14M |
YoY Change | 29.75% | ||
Common Stock | $200.2M | $197.0M | $184.7M |
YoY Change | 8.4% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $275.8M | $278.6M | $243.0M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $354.3M | $350.7M | $332.2M |
YoY Change | 6.65% | 28.05% | 45.13% |
Cashflow Statement
Concept | 2012 Q4 | 2012 Q3 | 2011 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.938M | $15.21M | -$5.938M |
YoY Change | 0.0% | 89.52% | -184.83% |
Depreciation, Depletion And Amortization | $3.500M | $2.900M | $2.600M |
YoY Change | 34.62% | 20.83% | 36.84% |
Cash From Operating Activities | $26.60M | $11.80M | $25.00M |
YoY Change | 6.4% | -296.67% | 157.73% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.700M | -$1.100M | -$3.200M |
YoY Change | -15.63% | -57.69% | 77.78% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$67.00M | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Cash From Investing Activities | -$69.70M | -$1.200M | -$3.200M |
YoY Change | 2078.13% | 1100.0% | -169.57% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 300.0K | 2.400M | 1.200M |
YoY Change | -75.0% | -64.71% | 140.0% |
NET CHANGE | |||
Cash From Operating Activities | 26.60M | 11.80M | 25.00M |
Cash From Investing Activities | -69.70M | -1.200M | -3.200M |
Cash From Financing Activities | 300.0K | 2.400M | 1.200M |
Net Change In Cash | -42.80M | 13.00M | 23.00M |
YoY Change | -286.09% | 1757.14% | 55.41% |
FREE CASH FLOW | |||
Cash From Operating Activities | $26.60M | $11.80M | $25.00M |
Capital Expenditures | -$2.700M | -$1.100M | -$3.200M |
Free Cash Flow | $29.30M | $12.90M | $28.20M |
YoY Change | 3.9% | -479.41% | 145.22% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2012Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
27756231 | shares |
CY2011Q3 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
9472000 | |
CY2005Q4 | irbt |
Effective Date For Stock Options Plan
EffectiveDateForStockOptionsPlan
|
2005-10-10 | |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
131662000 | |
CY2011Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
10259000 | |
CY2012Q2 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
8990000 | |
CY2012Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
346000 | |
CY2012Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2012Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
4608000 | |
CY2012Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
9037000 | |
CY2012Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4500000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
8187000 | |
CY2012Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
255000 | |
CY2012Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
68185000 | |
CY2012Q3 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
9546000 | |
CY2012Q3 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
20061000 | |
CY2012Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
350734000 | |
CY2012Q3 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
419000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
370000 | |
CY2012Q3 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
14882000 | |
CY2012Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
81375000 | |
CY2012Q3 | us-gaap |
Assets
Assets
|
350734000 | |
CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
169658000 | |
CY2012Q3 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
10424000 | |
CY2012Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
7104000 | |
CY2012Q3 | us-gaap |
Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
|
1693000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
2505000 | |
CY2012Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
53379000 | |
CY2012Q3 | us-gaap |
Inventory Net
InventoryNet
|
32592000 | |
CY2012Q3 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
9546000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
370000 | |
CY2012Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
85000 | |
CY2012Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
18599000 | |
CY2012Q3 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
4136000 | |
CY2012Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27725543 | shares |
CY2012Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
277000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2311000 | |
CY2012Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2012Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3940000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
2505000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
370000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
2574000 | |
CY2012Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
18713000 | |
CY2012Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
25488000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
92000 | |
CY2012Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2012Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
24838000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
740000 | |
CY2012Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27725543 | shares |
CY2012Q3 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
703000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
617000 | |
CY2012Q3 | us-gaap |
Assets Current
AssetsCurrent
|
296873000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
19016000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
370000 | |
CY2012Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3110000 | |
CY2012Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
196702000 | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2782000 | ||
CY2012Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
278609000 | |
CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2189000 | |
CY2012Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
2505000 | |
CY2012Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
38317000 | |
CY2012Q3 | irbt |
Deferred Revenue And Customer Advances
DeferredRevenueAndCustomerAdvances
|
2118000 | |
CY2012Q3 | irbt |
Accrued Direct Fulfillment Costs
AccruedDirectFulfillmentCosts
|
453000 | |
CY2012Q3 | irbt |
Increase In Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
IncreaseInShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
0.045 | pure |
CY2011Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
108383000 | |
CY2011Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
9284000 | |
CY2011Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
354000 | |
CY2011Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2011Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
7928000 | |
CY2011Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
17879000 | |
CY2011Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4500000 | |
CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
151000 | |
CY2011Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
85000000 | |
CY2011Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
10306000 | |
CY2011Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
411000 | |
CY2011Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
15344000 | |
CY2011Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
58140000 | |
CY2011Q4 | us-gaap |
Assets
Assets
|
332213000 | |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
166308000 | |
CY2011Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
6127000 | |
CY2011Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
7769000 | |
CY2011Q4 | us-gaap |
Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
|
2362000 | |
CY2011Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
43338000 | |
CY2011Q4 | us-gaap |
Inventory Net
InventoryNet
|
31089000 | |
CY2011Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
10306000 | |
CY2011Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
88000 | |
CY2011Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
12877000 | |
CY2011Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
||
CY2011Q4 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
17811000 | |
CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
332213000 | |
CY2011Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27216555 | shares |
CY2011Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
272000 | |
CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2033000 | |
CY2011Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2011Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4255000 | |
CY2011Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
17188000 | |
CY2011Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
23320000 | |
CY2011Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
143000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
9398000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
6572000 | ||
CY2011Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
29029000 | |
CY2011Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27216555 | shares |
CY2011Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
726000 | |
CY2011Q4 | us-gaap |
Assets Current
AssetsCurrent
|
284180000 | |
CY2011Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3484000 | |
CY2011Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2011Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
184395000 | |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
242958000 | |
CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2467000 | |
CY2011Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
48406000 | |
CY2011Q4 | irbt |
Deferred Revenue And Customer Advances
DeferredRevenueAndCustomerAdvances
|
1527000 | |
CY2011Q4 | irbt |
Accrued Direct Fulfillment Costs
AccruedDirectFulfillmentCosts
|
1907000 | |
irbt |
Increase In Revenue From Adjustment In Accrual Rates
IncreaseInRevenueFromAdjustmentInAccrualRates
|
3300000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7237000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10357000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
7946000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25823000 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26568000 | shares | |
us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
2556000 | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.31 | pure | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1176000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7344000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
38508000 | ||
us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
3531000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6386000 | ||
us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
3887000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
23279000 | ||
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
40301000 | ||
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
3100000 | ||
us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
5000000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
38250000 | ||
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
198699000 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.11 | ||
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-530000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
4829000 | ||
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
177695000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
6449000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
29553000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
258000 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.06 | ||
us-gaap |
Contract Revenue Cost
ContractRevenueCost
|
21004000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-476000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
31659000 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27823000 | shares | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14555000 | ||
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1255000 | shares | |
us-gaap |
Gross Profit
GrossProfit
|
136033000 | ||
us-gaap |
Contracts Revenue
ContractsRevenue
|
30632000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
29551000 | ||
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
126000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
97783000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8955000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-2000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10357000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
334732000 | ||
us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
6002000 | ||
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
304100000 | ||
us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
5000000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
300000 | shares | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1833000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
19081000 | ||
us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
6002000 | ||
irbt |
Income Tax Withholding Payment Associated With Restricted Stock Vesting
IncomeTaxWithholdingPaymentAssociatedWithRestrictedStockVesting
|
845000 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2012 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-09-29 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001159167 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-29 | ||
dei |
Trading Symbol
TradingSymbol
|
IRBT | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
IROBOT CORP | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8181000 | ||
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-315000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4022000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-3266000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12653000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
7166000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
26797000 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27520000 | shares | |
us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
2078000 | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.32 | pure | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
591000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
10041000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
34524000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-8842000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
32390000 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28323000 | shares | |
us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1318000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8023000 | ||
us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
-669000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3350000 | ||
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
45128000 | ||
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
3200000 | ||
us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
2500000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
34047000 | ||
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
197188000 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.84 | ||
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
1596000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1503000 | ||
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
184078000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2855000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
23235000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
477000 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.82 | ||
us-gaap |
Contract Revenue Cost
ContractRevenueCost
|
13110000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4706000 | ||
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
803000 | shares | |
us-gaap |
Gross Profit
GrossProfit
|
138362000 | ||
us-gaap |
Contracts Revenue
ContractsRevenue
|
14874000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
23339000 | ||
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
64000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
104315000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
11289000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
104000 | ||
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | Segment | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4067000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
335550000 | ||
us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
1461000 | ||
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
320676000 | ||
us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
5086000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-778000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
700000 | shares | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates these estimates and judgments, including those related to revenue recognition, sales returns, bad debts, warranty claims, inventory reserves, valuation of investments, assumptions used in valuing stock-based compensation instruments and income taxes. The Company bases these estimates on historical and anticipated results, and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from the Company’s estimates.</font></p> </div> | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-10089000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
11297000 | ||
us-gaap |
Fiscal Period
FiscalPeriod
|
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fiscal Year-End</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.</font></p> </div> | ||
us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
1461000 | ||
irbt |
Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
|
6000000 | ||
irbt |
Income Tax Withholding Payment Associated With Restricted Stock Vesting
IncomeTaxWithholdingPaymentAssociatedWithRestrictedStockVesting
|
777000 | ||
CY2012Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P4Y | |
CY2012Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
25.99 | |
CY2011Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8948000 | |
CY2011Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26902000 | shares |
CY2011Q4 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
479000 | |
CY2011Q4 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.31 | pure |
CY2011Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
15488000 | |
CY2011Q4 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1266000 | |
CY2011Q4 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
14553000 | |
CY2011Q4 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1100000 | |
CY2011Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
15580000 | |
CY2011Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
70330000 | |
CY2011Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.52 | |
CY2011Q4 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
63670000 | |
CY2011Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
14052000 | |
CY2011Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-92000 | |
CY2011Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.50 | |
CY2011Q4 | us-gaap |
Contract Revenue Cost
ContractRevenueCost
|
6660000 | |
CY2011Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10962000 | |
CY2011Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27940000 | shares |
CY2011Q4 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1038000 | shares |
CY2011Q4 | us-gaap |
Gross Profit
GrossProfit
|
50043000 | |
CY2011Q4 | us-gaap |
Contracts Revenue
ContractsRevenue
|
10380000 | |
CY2011Q4 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
13955000 | |
CY2011Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
34463000 | |
CY2011Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1436000 | |
CY2011Q4 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-97000 | |
CY2011Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
120373000 | |
CY2011Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
109993000 | |
CY2011Q4 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
500000 | shares |
CY2012Q2 | irbt |
Increase In Revenue From Adjustment In Accrual Rates
IncreaseInRevenueFromAdjustmentInAccrualRates
|
3300000 | |
CY2012Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8406000 | |
CY2012Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27650000 | shares |
CY2012Q3 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
524000 | |
CY2012Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.32 | pure |
CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
22931000 | |
CY2012Q3 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1080000 | |
CY2012Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
12436000 | |
CY2012Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1000000 | |
CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
22734000 | |
CY2012Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
71396000 | |
CY2012Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.55 | |
CY2012Q3 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
67008000 | |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15207000 | |
CY2012Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
197000 | |
CY2012Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
CY2012Q3 | us-gaap |
Contract Revenue Cost
ContractRevenueCost
|
4388000 | |
CY2012Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11326000 | |
CY2012Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28321000 | shares |
CY2012Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
671000 | shares |
CY2012Q3 | us-gaap |
Gross Profit
GrossProfit
|
54902000 | |
CY2012Q3 | us-gaap |
Contracts Revenue
ContractsRevenue
|
5124000 | |
CY2012Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
15257000 | |
CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
32168000 | |
CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7724000 | |
CY2012Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
50000 | |
CY2012Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
126298000 | |
CY2012Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
121174000 | |
CY2012Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
900000 | shares |
CY2012Q3 | irbt |
Increase In Revenue From Adjustment In Accrual Rates
IncreaseInRevenueFromAdjustmentInAccrualRates
|
7700000 |